EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:51230 - bimatoprost
| Formula | C25H37NO4 |
| Net Charge | 0 |
| Average Mass | 415.574 |
| Monoisotopic Mass | 415.27226 |
| SMILES | CCNC(=O)CCC/C=C\C[C@@H]1[C@@H](/C=C/[C@@H](O)CCc2ccccc2)[C@H](O)C[C@@H]1O |
| InChI | InChI=1S/C25H37NO4/c1-2-26-25(30)13-9-4-3-8-12-21-22(24(29)18-23(21)28)17-16-20(27)15-14-19-10-6-5-7-11-19/h3,5-8,10-11,16-17,20-24,27-29H,2,4,9,12-15,18H2,1H3,(H,26,30)/b8-3-,17-16+/t20-,21+,22+,23-,24+/m0/s1 |
| InChIKey | AQOKCDNYWBIDND-FTOWTWDKSA-N |
| Roles Classification |
|---|
| Applications: | antiglaucoma drug Any drug which can be used to prevent or alleviate glaucoma, a disease in which the optic nerve is damaged, resulting in progressive, irreversible loss of vision. It is often, though not always, associated with increased pressure of the fluid in the eye. antihypertensive agent Any drug used in the treatment of acute or chronic vascular hypertension regardless of pharmacological mechanism. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| bimatoprost (CHEBI:51230) has role antiglaucoma drug (CHEBI:39456) |
| bimatoprost (CHEBI:51230) has role antihypertensive agent (CHEBI:35674) |
| bimatoprost (CHEBI:51230) is a monocarboxylic acid amide (CHEBI:29347) |
| IUPAC Name |
|---|
| (5Z)-7-{(1R,2R,3R,5S)-3,5-dihydroxy-2-[(1E,3S)-3-hydroxy-5-phenylpent-1-en-1-yl]cyclopentyl}-N-ethylhept-5-enamide |
| INNs | Source |
|---|---|
| bimatoprost | ChemIDplus |
| bimatoprostum | WHO MedNet |
| Synonyms | Source |
|---|---|
| bimatoprost | WHO MedNet |
| (Z)-7-((1R,2R,3R,5S)-3,5-Dihydroxy-2-((1E,3S)-3-hydroxy-5-phenyl-1-pentenyl)cyclopentyl)-N-ethyl-5-heptenamide | ChemIDplus |
| Registry Numbers | Sources |
|---|---|
| CAS:155206-00-1 | ChemIDplus |